Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Lovesac Company

PayPal

Investing great Warren Buffett's success can at least partially be attributed to portfolio concentration. An outsized percentage of my invested assets are currently being put to work in a relatively small number of my top investment ideas.

I Own 46 Stocks -- but These Are the 3 I Can't Stop Buying in 2023

Kinder Morgan

Western Digital

Recent information reported by Bloomberg about 2024 refinancing issues suggests many large debt-heavy stocks to avoid in the coming year. THis leads to us coming up with our list of stocks vulnerable to refinancing.

High Debt, High Risk: 3 Stocks Vulnerable to Refinancing Woes

Walgreens Boots Alliance has appointed a new CEO and will focus on turning its Healthcare segment profitable. The company has embarked on a $1 billion cost-cutting plan and could sell assets to help reduce debt. With a low bar set, the stock could be a good rebound candidate next year.

Walgreens Boots Alliance: Upgrading To Buy Based On Cost Cuts And Low Bar

Walgreens Boots Alliance is transitioning to a healthcare-focused company under new CEO Tim Wentworth. The company is facing increasing competition from Amazon and other low-cost retailers in the healthcare services space. Management seems to be avoiding a conversation of the dividend sustainability. I think a dividend cut would enable growth.

Walgreens: This Dog Of The Dow Will Have To Cut Their Dividend To Enable Growth

Walgreens Boots Alliance stock has wilted over the past 12 months. As a result, its dividend yield has ballooned to 9% at current levels.

Is This Ultra-High-Yield Dividend Stock a Buy?

AllianceBernstein Hld

Ares Commercial Real Estate

BrightSpire Capital

FS KKR Capital Corp

AG Mortgage Investment Trust

Altria

ETRACS Monthly Pay 1.5X Leveraged Mortgage REIT ETN

OFS Capital

Oxford Lane Capital

Petroleo Brasileiro

Ready Capital Corp

AT&T

AT&T 5.35 % Notes 2017-01.11.66 Global

Invesco Senior Income Trust

Prior to September 30, 2023, my Readers mentioned 36 equities in their comments on my articles. Some bad-news investments (Rogues) mixed with (mostly) Favorites. Thus, these are ReFa/Ro. Ten analyst-target-estimated TOP-NET-GAIN Re/Fa/Ro: MVRL, FSK, T, RC, MO, BRSP, AHOTF, AB, WBA, and MITT averaged 56.52% net gains from reader data collected 11/15/23. Ten analyst-target-augured October TOP-PRICE-UPSIDE reader faves & rogues (ReFa/Ro) were: ABR, MMM, RC, O, BRSP, MO, T, AB, WBA, & MITT boasting a 47.19% average target price upside estimate.

Readers Post 31 October Dividend Buy Candidates

Cogent Communications Holdings

Innovative Industrial Properties

While there are many ways to generate significant returns in the market, one of the safest approaches is to invest in dividend stocks. Of course, you can earn income through bonds and savings accounts, too.

3 Dividend Stocks Yielding Over 5% for Steady Income

Blue-chip pharmaceutical stock Walgreens Boots Alliance (NASDAQ:WBA) is underperforming on the charts, recently hitting a Nov. 13 record low of $20.00.

Don't Bet on Walgreens Boots Alliance Stock's Bounce Just Yet

Walgreens Boots Alliance will close nearly all of its stores and pharmacies on Thanksgiving Day for the first time in the chain's history to give staff "time with their loved ones", the company said on Thursday.

Walgreens to close nearly all pharmacies on Thanksgiving for first time

Walgreens Boots Alliance Inc. WBA, -3.41% said Thursday that it will close nearly all of its stores and pharmacies for the Thanksgiving holiday, for the first time in the company's history. The company, which had a total of 8,701 retail stores in the U.S. as of Aug. 31, said however that nearly all of its 700 Walgreens 24-hour locations will remain open on Thanksgiving (Nov. 23).

Walgreens to close ‘nearly all' of its stores and pharmacies for Thanksgiving, for the first time in its history

DEERFIELD, Ill.--(BUSINESS WIRE)--On Thanksgiving Day, most Walgreens locations will be closed. Nearly all 700 Walgreens 24-hour locations will remain open on Thanksgiving to help meet the healthcare needs of our customers. This is the first time Walgreens has closed stores on Thanksgiving Day to give time back to its workforce. “We have consistently heard from our team members—who are the face of Walgreens—that time off is a meaningful way for us to demonstrate we value them,” said Tracey D. B.

Walgreens Stores to Close for Thanksgiving Holiday

CVS Health

The world of financial markets can be a brutal jungle, filled with dangers at every turn and businesses going bankrupt or turning billionaires almost overnight. Today, some of these risks and uncertain turning points have been assessed to bring you a sensible list of companies that can be termed as value stocks.

3 value stocks you shouldn't let go of this quarter

Walgreens is taking a new approach to online delivery by utilizing its network of physical stores.  The pharmacy giant recently closed a warehouse dedicated to eCommerce orders, signaling its commitment to using its 8,700 stores as both retail outlets and fulfillment centers, The Wall Street Journal (WSJ) reported Tuesday (Nov. 14).

Walgreens Shifts eCommerce Fulfillment From Warehouses to Retail Stores

Problems are piling up at Walgreens — not least among them a bizarre, $200 million legal tussle with one of the drugstore giant's vendors that has become “very awkward” for the company's 82-year-old chairman, The Post has learned.

Walgreens' billionaire chairman caught in ‘very awkward' legal tussle as drugstore giant's problems continue to pile up

Realty Income Corp

Verizon

Dividends should be seen as a reduction in a stock's intrinsic value over time and as capital appreciation that otherwise would have been achieved had the dividend not been paid. Empirically, the higher the dividend yield the past 10 years, the lower the total return. Dividend-only-focused investors likely have underperformed the past decade. Realty Income, Verizon, and Walgreens are three popular dividend stocks that investors should avoid due to financial concerns.

3 Popular Dividend Stocks To Avoid

Best Buy

Ford Motor Company

Pfizer

Marketbeat's stock screening tools are a wealth of investment ideas, including the 52-week low list. Stocks trading at 52-week lows often provide oversold value ready to spring back, given the right catalysts.

4 high yields near 52-week lows worth looking at

Shares of drugstore chain Walgreens Boots Alliance Inc. WBA, -0.86% were down 0.9% and trading at $20.11 on Monday, putting the stock on pace for its lowest close since Aug. 31, 1998, when it finished at $19.19. The stock, currently the worst performer in the Dow today, has fallen 46% year to date, and is on track for its worst year on record.

Walgreens Boots is the Dow's worst performer today, on pace for its lowest close in roughly 25 years and its worst year ever

Walgreens has sold shares of drug distributor Cencora, formerly AmerisourceBergen, for proceeds of $674 million, which will be used “debt paydown and general corporate purposes.”

Under New CEO Wentworth, Walgreens Continues To Sell Off Distributor Stake

Walgreens Boots Alliance (WBA) concluded the recent trading session at $20.76, signifying a +1.52% move from its prior day's close.

Walgreens Boots Alliance (WBA) Rises But Trails Market: What Investors Should Know

Burlington Stores

Campbell Soup

DISH Network

Etsy

Harley-Davidson

Macy's

Paramount Global

Harley-Davidson, Macy's, and Etsy are among the market's biggest losers this year.

'Tis the Season for Tax-Loss Selling. Short These Stocks.

Walgreens (NASDAQ: WBA ) layoffs are coming to the pharmacy company's corporate employees at its headquarters in Deerfield, Ill. Walgreens is going to reduce its corporate headcount by 5% at its headquarters.

Walgreens Layoffs 2023: What to Know About the Latest WBA Job Cuts

Cencora Inc

Drugstore chain Walgreens Boots Alliance Inc. WBA, -2.62% on Thursday said it had sold shares of drug distributor Cencora Inc. COR, +0.02% for approximately $424 million. Walgreens also entered into a share repurchase by Cencora, formerly known as AmerisourceBergen, for proceeds of roughly $250 million.

Walgreens sells shares of drug distributor Cencora

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) (the “Company”) today announced that it has sold shares of Cencora, Inc. (NYSE: COR) (“Cencora”) common stock pursuant to variable prepaid forward transactions executed in reliance on Rule 144 under the Securities Act of 1933, as amended, for current proceeds of approximately $424 million and, depending on the stock price at the time, potentially additional proceeds at maturity. In addition, and subject to the closin.

Walgreens Boots Alliance Sells Shares of Cencora, Inc. for $674 Million of Initial Proceeds

Walgreens has been investing billions into its new healthcare business. The company only expects it to be profitable on an adjusted basis this fiscal year.

1 Big Problem With Walgreens Boots Alliance's Healthcare Strategy

Salesforce

NVIDIA

Bristol-Myers

Crown Castle International

Citizens Financial Group

Comerica

Eversource Energy

KeyCorp

Moderna

Charles Schwab

J. M. Smucker

Truist Financial

Tapestry

Stocks' yearly performance rankings are a field day for contrarians: One year's worst often are the subsequent year's best, and vice versa.

News for Walgreens Stock (WBA)